Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Capri Holdings
CPRI
|
+$479M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$246M |
| 3 |
AGN
ALLERGAN INC
AGN
|
+$241M |
| 4 |
Apple
AAPL
|
+$229M |
| 5 |
Tesla
TSLA
|
+$188M |
Top Sells
| 1 |
IBM
IBM
|
+$660M |
| 2 |
Intuitive Surgical
ISRG
|
+$501M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$476M |
| 4 |
Broadcom
AVGO
|
+$375M |
| 5 |
Crown Castle
CCI
|
+$373M |
Sector Composition
| 1 | Healthcare | 17.32% |
| 2 | Consumer Discretionary | 14.66% |
| 3 | Technology | 10.42% |
| 4 | Energy | 9.58% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Chevron
CVX
$310B
| $3.32M | ﹤0.01% |
+27,316
| New | +$3.32M |
|
527
BioCryst Pharmaceuticals
BCRX
$1.72B
| $3.28M | ﹤0.01% |
+450,000
| New | +$3.28M |
|
528
Archer Daniels Midland
ADM
$29.9B
| $3.27M | ﹤0.01% |
+88,692
| New | +$3.27M |
|
529
Intel
INTC
$107B
| $3.26M | ﹤0.01% |
142,076
+22,141
| +18% | +$507K |
|
530
Lockheed Martin
LMT
$107B
| $3.2M | ﹤0.01% |
+25,082
| New | +$3.2M |
|
|
CB
531
DELISTED
CHUBB CORPORATION
CB
| $3.17M | ﹤0.01% |
+35,562
| New | +$3.17M |
|
532
DuPont de Nemours
DD
$32.6B
| $3.14M | ﹤0.01% |
+40,502
| New | +$3.14M |
|
533
Eli Lilly
LLY
$662B
| $3.13M | ﹤0.01% |
+62,236
| New | +$3.13M |
|
534
Alaunos Therapeutics
TCRT
$4.33M
| $3.09M | ﹤0.01% |
+5,223
| New | +$3.09M |
|
535
Johnson & Johnson
JNJ
$429B
| $3.03M | ﹤0.01% |
34,971
+3,401
| +11% | +$295K |
|
536
CSX Corp
CSX
$60.5B
| $3.02M | ﹤0.01% |
+352,101
| New | +$3.02M |
|
|
SUSQ
537
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
| $3.02M | ﹤0.01% |
240,523
-20,348
| -8% | -$255K |
|
538
Lindsay Corp
LNN
$1.52B
| $3M | ﹤0.01% |
36,762
+4,616
| +14% | +$377K |
|
539
DexCom
DXCM
$30.6B
| $2.99M | ﹤0.01% |
423,732
+92,896
| +28% | +$656K |
|
540
Blackrock
BLK
$171B
| $2.95M | ﹤0.01% |
10,905
+43
| +0.4% | +$11.6K |
|
541
NETGEAR
NTGR
$817M
| $2.9M | ﹤0.01% |
94,115
-1,171,087
| -93% | -$36.1M |
|
542
Berkshire Hathaway Class B
BRK.B
$1.07T
| $2.9M | ﹤0.01% |
+25,558
| New | +$2.9M |
|
543
Nordson
NDSN
$12.7B
| $2.84M | ﹤0.01% |
38,597
-268,442
| -87% | -$19.8M |
|
|
HTS
544
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $2.74M | ﹤0.01% |
146,476
+29,025
| +25% | +$543K |
|
545
Macy's
M
$4.57B
| $2.73M | ﹤0.01% |
+63,156
| New | +$2.73M |
|
546
Meritage Homes
MTH
$5.84B
| $2.73M | ﹤0.01% |
127,034
+26,384
| +26% | +$567K |
|
547
Conagra Brands
CAG
$9.32B
| $2.7M | ﹤0.01% |
+114,194
| New | +$2.7M |
|
548
iShares Russell 1000 Growth ETF
IWF
$118B
| $2.53M | ﹤0.01% |
32,333
-15
| -0% | -$1.17K |
|
|
QLTI
549
DELISTED
QLT Inc
QLTI
| $2.53M | ﹤0.01% |
546,112
| – | – |
|
550
Watts Water Technologies
WTS
$9.47B
| $2.52M | ﹤0.01% |
44,707
-11,805
| -21% | -$665K |
|